Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) was down 5% during trading on Friday . The company traded as low as $0.16 and last traded at $0.16. Approximately 14,356 shares traded hands during trading, an increase of 30% from the average daily volume of 11,052 shares. The stock had previously closed at $0.17.
Alpha Tau Medical Stock Down 5.0 %
The stock’s fifty day moving average is $0.19 and its two-hundred day moving average is $0.21.
About Alpha Tau Medical
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Featured Articles
- Five stocks we like better than Alpha Tau Medical
- What is a Special Dividend?
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- 3 Fintech Stocks With Good 2021 Prospects
- Top-Performing Non-Leveraged ETFs This Year
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
